Clinical Trial Update: Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety and efficacy of SCT200 in head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• SCT200

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Head and Neck Cancer | Phase 2 | Status: UNKNOWN